Comparison of the Effect of Chlorhexidine Mouthwash with Matrika Mouthwash Drop on Probable Ventilator-associated Pneumonia in Intensive Care Unit
AbstractBackground: Daily use of Chlorhexidine mouthwash following endotracheal intubation is done routinely in intensive care units (ICU). Matrika (Chamomile extract) has shown antibiotic activities, and several articles report it has similar preventive effect as Chlorhexidine on ventilator associated pneumonia, and also on oral cavity hygiene. Our study aimed to compare rate of VAP occurrence in two groups of intubated patients receiving Chlorhexidine and Matrika in Alzahra hospital’s ICU. Methods: In this trial 90 ICU patients who were intubated endotracheally, were randomly divided into two groups who will receive one of Chlorhexidine (group A) or Matrika (group B) mouthwash every 8 hours. Occurrence of VAP was determined in the following 5 days after intubation, using the standard VAP diagnosis criterion. Results: 8 of 45 (17%) patients experienced VAP in the first five days after intubation in the Chlorhexidine group, and, 9 of 45 (20%) patients in the Matrika group experienced the same condition. VAP rate was not significantly lower in the Chlorhexidine group (p value= 0.73). Conclusion: The results show that VAP occurs in Chlorhexidine and Matrika group approximately at a similar rate. Our findings recommend further studies on Matrika as an alternative to Chlorhexidine.
Munro CL, Grap MJ, Sessler CN, Elswick RK Jr, Mangar D, Karlnoski-Everall R, et al. Preintubation application of oral chlorhexidine does not provide additional benefit in prevention of early-onset ventilator-associated pneumonia. Chest. 2015; 147(2):328-34.
Berry AM, Davidson PM, Masters J, Rolls K. Systematic literature review of oral hygiene practices for intensive care patients receiving mechanical ventilation. Am J Crit Care. 2007;16(6):552-62.
Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care. 2002; 11(6):567-70.
Vilela MC, Ferreira GZ, Santos PS, Rezende NP. Oral care and nosocomial pneumonia: a systematic review. Einstein (Sao Paulo). 2015; 13(2):290-6.
Goldman L, Austiello D. Cecil textbook of medicine. 23rd ed. Philadelphia: Elsevier, 2007.
Safdar N, Crinch CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005; 50(6):725-39.
Nicolosi LN, del Carmen Rubio M, Martinez CD, González NN, Cruz ME. Effect of oral hygiene and 0.12% chlorhexidine gluconate oral rinse in preventing ventilator-associated pneumonia after cardiovascular surgery. Respir Care. 2014; 59(4):504-9
Lindhe J, Karring T, Lang N. Periodontology and implant dentistry. Munksguard: Blackwell; 2003.
Munro CL. Oral health: something to smile about! Am J Crit Care. 2014; 23(4):282-8.
Enwere EN, Elofson KA, Forbes RC, Gerlach AT. Impact of chlorhexidine mouthwash prophylaxis on probable ventilator-associated pneumonia in a surgical intensive care unit. Int J Crit Illn Inj Sci. 2016; 6(1):3-8.
Kusahara DM, Peterlini MA, Pedreira ML. Oral care with 0.12% chlorhexidine for the prevention of ventilator-associated pneumonia in critically ill children: randomised, controlled and double blind trial. Int J Nurs Stud. 2012; 49(11):1354-63.
Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman MC. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect (Larchmt). 2001; 2(1):5-18.
Özçaka Ö, Başoğlu OK, Buduneli N, Taşbakan MS, Bacakoğlu F, Kinane DF. Chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients: a randomized clinical trial. J Periodontal Res. 2012; 47(5):584-92.
Song X, Chen Y, Li X. Differences in incidence and outcome of ventilator-associated pneumonia in surgical and medical ICUs in a tertiary hospital in China. Clin Respir J. 2014; 8(3):262-8.
Conley P, McKinsey D, Graff J, Ramsey AR. Does an oral care protocol reduce VAP in patients with a tracheostomy? Nursing. 2013; 43(7):18-23.
Shi Z, Xie H, Wang P, Zhang Q, Wu Y, Chen E, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev. 2013; 8:CD008367.
Azab SF, Sherbiny HS, Saleh SH, Elsaeed WF, Elshafiey MM, Siam AG, et al. Reducing ventilator-associated pneumonia in neonatal intensive care unit using "VAP prevention Bundle": a cohort study. BMC Infect Dis. 2015; 15:314.
Lis-Balchin Maria. Aromatherapy science: A guide for healthcare professionals. Pharmaceutical Press. 2006:150-154.
Pourabbas Reza, Delazar Abbas, Chitsaz Mohammad Taghi. The Effect of German Chamomile Mouthwash on Dental Plaque and Gingival Inflammation. Iranian journal of Pharmaceutical Research. 2005; 2:105-9.
Lis-Balchin M. Serious adverse effects between herbal remedies and conventional drugs taken simultaneously. J R Soc Promot Health. 2002; 122(4):210.
Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014; 18(2):208.
Kanafani ZA, Kara L, Hayek S, Kanj SS. Ventilator-associated pneumonia at a tertiary-care center in a developing country: Incidence, microbiology and susceptibility patterns of isolated microorganisms. Infect Control Hosp Epidemiol. 2003; 24(11):864-9.
Goes P, Dutra CS, Lisboa MR, Gondim DV, Leitão R, Brito GA, et al. Clinical efficacy of a 1% Matricaria chamomile L. mouthwash and 0.12% chlorhexidine for gingivitis control in patients undergoing orthodontic treatment with fixed appliances. J Oral Sci. 2016; 58(4):569-574.
Azimi M, Jouybari L, Moghadam S, Ghaemi E, Behnampoor N, Sanagoo A, et al. Antimicrobial effects of chlorhexidine, matrica drop mouthwash (chamomile extract), and normal saline on hospitalized patients with endotracheal tubes. Iran J Nurs Midwifery Res. 2016; 21(5):458-463.
Paknejad M, Jafarzadeh T, Shamloo A. Comparison of the efficacy of Matrica and %0.2 Chlorhexidine mouthwashes on 3-6 mm pockets in patients with chronic periodontitis. The Journal of Islamic Dental Association of IRAN (JIDA). 2006; 18 (3):92-7.
Atai Z, Abdollahi H, Naderipour S, Mohammadi S. Comparison of antifungal and antibacterial effects of Persica Matrica and Iralwex with Chlorhexidine mouthwashes (An in vitro study). J Dent Sch. 2007; 25 (1) :58-65
Firouzian A, Darvishi-Khezri H. Comparison of the antibacterial effects of Persica, Matrica and chlorhexidine gluconate mouthwashes and normal saline in mechanically ventilated ICU patients: A clinical trial. Feyz Journal of Kashan University of Medical Sciences. 19(6):486-94.
Safarabadi M, Rezaei K, Ghaznavirad E. Comparing the effect of Echinacea and chlorhexidine mouthwash on oral health in patients hospitalized in intensive care units. Complementary Medicine Journal of faculty of Nursing & Midwifery. 2012; 2(3):222-234.
Gholami Mehrabadi M, Khosravi Sh, Rezaie K, Malekianzadeh B, Ghorbanpour M, Moslemi A, et al. The effect of Echinacea mouthwash on ventilator associated pneumonia in patients in intensive care units. Medical - Surgical Nursing Journal. 2015; 4(3): 13-20.
Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, et al. Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014; (10):CD009066.
Halm MA, Armola R. Effect of Oral Care on Bacterial Colonization and Ventilator-Associated Pneumonia. Am J Crit Care. 2009; 18(3):275-8.
Munro CL, Grap MJ. Oral health and care in the intensive care unit: state of the science. Am J Crit Care. 2004; 13(1):25-33.